pmc logo image
Logo of aacAntimicrob Agents Chemother SubscriptionsAntimicrob Agents Chemother Web Site
Journal List > Antimicrob Agents Chemother > v.40(4); Apr 1996

Formats:
Antimicrob Agents Chemother. 1996 April; 40(4): 934–940.
PMCID: PMC163234
Copyright notice
The tetracycline derivative minocycline differentially affects cytokine production by monocytes and T lymphocytes.
M Kloppenburg, B M Brinkman, H H de Rooij-Dijk, A M Miltenburg, M R Daha, F C Breedveld, B A Dijkmans, and C Verweij
Department of Rheumatology, University Hospital, Leiden, The Netherlands.
Small right arrow pointing to: This article has been cited by other articles in PMC.
Abstract
Minocycline is a tetracycline derivative that has beneficial effects in noninfectious forms of arthritis and dermatitis. To investigate whether this effect may be attributed to interference with cytokine production, we studied the effect of minocycline on cytokine production by T cells and monocytes. Minocycline exerted an inhibitory effect on tumor necrosis factor alpha (TNF-alpha) and gamma interferon production by stimulated T cells, whereas the production of interleukin 6 (IL-6) remained unaffected. The effect of minocycline on TNF-alpha mRNA synthesis by T cells was shown to be stimulus specific. T cells stimulated by a Ca2+-independent mode exhibited a decrease in TNF-alpha mRNA in the presence of minocycline, whereas the TNF-alpha mRNA level remained unaffected by minocycline when cells were stimulated in a Ca2+-dependent manner. In contrast to the effect on T cells, addition of minocycline to lipopolysaccharide-stimulated monocytes led to a dose-dependent increase in TNF-alpha and IL-6 production which was paralleled by an enhancement of TNF-alpha mRNA synthesis. These results indicate that minocycline exerts differential effects on the regulation of cytokine production by T cells and monocytes that are partly reflected at the mRNA level. Given the pleiotropic effects of minocycline, it is suggested that the immunostimulatory effect on monocytes might counteract its beneficial properties in the treatment of several forms of chronic inflammation.
Full Text
The Full Text of this article is available as a PDF (358K).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
  • Aarden L, Helle M, Boeije L, Pascual-Salcedo D, de Groot E. Differential induction of interleukin-6 production in monocytes, endothelial cells and smooth muscle cells. Eur Cytokine Netw. 1991 Mar–Apr;2(2):115–120. [PubMed]
  • ALBERT A, REES CW. Avidity of the tetracyclines for the cations of metals. Nature. 1956 Mar 3;177(4505):433–434. [PubMed]
  • Banck G, Forsgren A. Antibiotics and suppression of lymphocyte function in vitro. Antimicrob Agents Chemother. 1979 Nov;16(5):554–560. [PubMed]
  • Bax CM, Shankar VS, Towhidul Alam AS, Bax BE, Moonga BS, Huang CL, Zaidi M, Rifkin BR. Tetracyclines modulate cytosolic Ca2+ responses in the osteoclast associated with "Ca2+ receptor" activation. Biosci Rep. 1993 Jun;13(3):169–174. [PubMed]
  • Beaty CD, Franklin TL, Uehara Y, Wilson CB. Lipopolysaccharide-induced cytokine production in human monocytes: role of tyrosine phosphorylation in transmembrane signal transduction. Eur J Immunol. 1994 Jun;24(6):1278–1284. [PubMed]
  • Bellahsene A, Forsgren A. Effect of doxycycline on immune response in mice. Infect Immun. 1985 May;48(2):556–559. [PubMed]
  • Bloemena E, Van Oers RH, Weinreich S, Stilma-Meinesz AP, Schellekens PT, Van Lier RA. The influence of cyclosporin A on the alternative pathways of human T cell activation in vitro. Eur J Immunol. 1989 May;19(5):943–946. [PubMed]
  • Bouaboula M, Legoux P, Pességué B, Delpech B, Dumont X, Piechaczyk M, Casellas P, Shire D. Standardization of mRNA titration using a polymerase chain reaction method involving co-amplification with a multispecific internal control. J Biol Chem. 1992 Oct 25;267(30):21830–21838. [PubMed]
  • Braegger CP, Nicholls S, Murch SH, Stephens S, MacDonald TT. Tumour necrosis factor alpha in stool as a marker of intestinal inflammation. Lancet. 1992 Jan 11;339(8785):89–91. [PubMed]
  • Brennan FM, Maini RN, Feldmann M. TNF alpha--a pivotal role in rheumatoid arthritis? Br J Rheumatol. 1992 May;31(5):293–298. [PubMed]
  • Cerami A, Beutler B. The role of cachectin/TNF in endotoxic shock and cachexia. Immunol Today. 1988 Jan;9(1):28–31. [PubMed]
  • De Jonge HR. Toxicity of tetracyclines in rat-small-intestinal epithelium and liver. Biochem Pharmacol. 1973 Nov 1;22(21):2659–2677. [PubMed]
  • Derkx B, Taminiau J, Radema S, Stronkhorst A, Wortel C, Tytgat G, van Deventer S. Tumour-necrosis-factor antibody treatment in Crohn's disease. Lancet. 1993 Jul 17;342(8864):173–174. [PubMed]
  • Elliott MJ, Maini RN, Feldmann M, Kalden JR, Antoni C, Smolen JS, Leeb B, Breedveld FC, Macfarlane JD, Bijl H, et al. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis. Lancet. 1994 Oct 22;344(8930):1105–1110. [PubMed]
  • Pepper GM, Maimon J, Schneider BS. Quantification and characterization of ACTH-related peptides produced by human peripheral blood mononuclear cells. Lymphokine Cytokine Res. 1991 Apr;10(1-2):133–140. [PubMed]
  • Feldmann M, Brennan FM, Chantry D, Haworth C, Turner M, Abney E, Buchan G, Barrett K, Barkley D, Chu A, et al. Cytokine production in the rheumatoid joint: implications for treatment. Ann Rheum Dis. 1990 Jun;49 (Suppl 1):480–486. [PubMed]
  • Golub LM, Lee HM, Lehrer G, Nemiroff A, McNamara TF, Kaplan R, Ramamurthy NS. Minocycline reduces gingival collagenolytic activity during diabetes. Preliminary observations and a proposed new mechanism of action. J Periodontal Res. 1983 Sep;18(5):516–526. [PubMed]
  • Goodhart GL. Further evidence for the role of bivalent cations in human polymorphonuclear leukocyte locomotion: recovery from tetracycline-induced inhibition in the presence of cation ionophores. J Reticuloendothel Soc. 1979 May;25(5):545–554. [PubMed]
  • Grau GE, Fajardo LF, Piguet PF, Allet B, Lambert PH, Vassalli P. Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria. Science. 1987 Sep 4;237(4819):1210–1212. [PubMed]
  • Greenwald RA, Golub LM, Lavietes B, Ramamurthy NS, Gruber B, Laskin RS, McNamara TF. Tetracyclines inhibit human synovial collagenase in vivo and in vitro. J Rheumatol. 1987 Feb;14(1):28–32. [PubMed]
  • Helle M, Boeije L, de Groot E, de Vos A, Aarden L. Sensitive ELISA for interleukin-6. Detection of IL-6 in biological fluids: synovial fluids and sera. J Immunol Methods. 1991 Apr 8;138(1):47–56. [PubMed]
  • Humbert P, Treffel P, Chapuis JF, Buchet S, Derancourt C, Agache P. The tetracyclines in dermatology. J Am Acad Dermatol. 1991 Oct;25(4):691–697. [PubMed]
  • Imboden JB, Weiss A, Stobo JD. The antigen receptor on a human T cell line initiates activation by increasing cytoplasmic free calcium. J Immunol. 1985 Feb;134(2):663–665. [PubMed]
  • Ingham E. Modulation of the proliferative response of murine thymocytes stimulated by IL-1, and enhancement of IL-1 beta secretion from mononuclear phagocytes by tetracyclines. J Antimicrob Chemother. 1990 Jul;26(1):61–70. [PubMed]
  • Ingham E, Turnbull L, Kearney JN. The effects of minocycline and tetracycline on the mitotic response of human peripheral blood-lymphocytes. J Antimicrob Chemother. 1991 May;27(5):607–617. [PubMed]
  • Jäättelä M. Biologic activities and mechanisms of action of tumor necrosis factor-alpha/cachectin. Lab Invest. 1991 Jun;64(6):724–742. [PubMed]
  • June CH, Ledbetter JA, Gillespie MM, Lindsten T, Thompson CB. T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression. Mol Cell Biol. 1987 Dec;7(12):4472–4481. [PubMed]
  • Kloppenburg M, Breedveld FC, Terwiel JP, Mallee C, Dijkmans BA. Minocycline in active rheumatoid arthritis. A double-blind, placebo-controlled trial. Arthritis Rheum. 1994 May;37(5):629–636. [PubMed]
  • Kloppenburg M, Mattie H, Douwes N, Dijkmans BA, Breedveld FC. Minocycline in the treatment of rheumatoid arthritis: relationship of serum concentrations to efficacy. J Rheumatol. 1995 Apr;22(4):611–616. [PubMed]
  • Kloppenburg M, Verweij CL, Miltenburg AM, Verhoeven AJ, Daha MR, Dijkmans BA, Breedveld FC. The influence of tetracyclines on T cell activation. Clin Exp Immunol. 1995 Dec;102(3):635–641. [PubMed]
  • Langevitz P, Bank I, Zemer D, Book M, Pras M. Treatment of resistant rheumatoid arthritis with minocycline: an open study. J Rheumatol. 1992 Oct;19(10):1502–1504. [PubMed]
  • Mandrup-Poulsen T, Bendtzen K, Nielsen JH, Bendixen G, Nerup J. Cytokines cause functional and structural damage to isolated islets of Langerhans. Allergy. 1985 Aug;40(6):424–429. [PubMed]
  • Novogrodsky A, Vanichkin A, Patya M, Gazit A, Osherov N, Levitzki A. Prevention of lipopolysaccharide-induced lethal toxicity by tyrosine kinase inhibitors. Science. 1994 May 27;264(5163):1319–1322. [PubMed]
  • Potts RC, Hassan HA, Brown RA, MacConnachie A, Gibbs JH, Robertson AJ, Beck JS. In vitro effects of doxycycline and tetracycline on mitogen stimulated lymphocyte growth. Clin Exp Immunol. 1983 Aug;53(2):458–464. [PubMed]
  • Rijkers GT, Van Oosterom R, Van Muiswinkel WB. The immune system of cyprinid fish. Oxytetracycline and the regulation of humoral immunity in carp (Cyprinus carpio). Vet Immunol Immunopathol. 1981 Jun;2(3):281–290. [PubMed]
  • Roche Y, Fay M, Gougerot-Pocidalo MA. Interleukin-1 production by antibiotic-treated human monocytes. J Antimicrob Chemother. 1988 May;21(5):597–607. [PubMed]
  • Saivin S, Houin G. Clinical pharmacokinetics of doxycycline and minocycline. Clin Pharmacokinet. 1988 Dec;15(6):355–366. [PubMed]
  • Saxne T, Palladino MA, Jr, Heinegård D, Talal N, Wollheim FA. Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum. Arthritis Rheum. 1988 Aug;31(8):1041–1045. [PubMed]
  • Thong YH, Ferrante A. Inhibition of mitogen-induced human lymphocyte proliferative responses by tetracycline analogues. Clin Exp Immunol. 1979 Mar;35(3):443–446. [PubMed]
  • Thong YH, Ferrante A. Effect of tetracycline treatment on immunological responses in mice. Clin Exp Immunol. 1980 Mar;39(3):728–732. [PubMed]
  • Tilley BC, Alarcón GS, Heyse SP, Trentham DE, Neuner R, Kaplan DA, Clegg DO, Leisen JC, Buckley L, Cooper SM, Duncan H, Pillemer SR, Tuttleman M, Fowler SE. Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group. Ann Intern Med. 1995 Jan 15;122(2):81–89. [PubMed]
  • Truneh A, Albert F, Golstein P, Schmitt-Verhulst AM. Early steps of lymphocyte activation bypassed by synergy between calcium ionophores and phorbol ester. Nature. 313(6000):318–320. [PubMed]
  • van den Bogert C, Dontje BH, Holtrop M, Melis TE, Romijn JC, van Dongen JW, Kroon AM. Arrest of the proliferation of renal and prostate carcinomas of human origin by inhibition of mitochondrial protein synthesis. Cancer Res. 1986 Jul;46(7):3283–3289. [PubMed]
  • Van den Bogert C, Kroon AM. Effects of oxytetracycline on in vivo proliferation and differentiation of erythroid and lymphoid cells in the rat. Clin Exp Immunol. 1982 Nov;50(2):327–335. [PubMed]
  • Van der Meide PH, Dubbeld M, Schellekens H. Monoclonal antibodies to human immune interferon and their use in a sensitive solid-phase ELISA. J Immunol Methods. 1985 May 23;79(2):293–305. [PubMed]
  • van Kooten C, Rensink I, Pascual-Salcedo D, van Oers R, Aarden L. Monokine production by human T cells; IL-1 alpha production restricted to memory T cells. J Immunol. 1991 Apr 15;146(8):2654–2658. [PubMed]
  • Vilcek J, Lee TH. Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions. J Biol Chem. 1991 Apr 25;266(12):7313–7316. [PubMed]
  • Weiss A, Wiskocil RL, Stobo JD. The role of T3 surface molecules in the activation of human T cells: a two-stimulus requirement for IL 2 production reflects events occurring at a pre-translational level. J Immunol. 1984 Jul;133(1):123–128. [PubMed]
Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of
American Society for Microbiology (ASM)